DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Hirschfield GM, Gershwin ME, Strauss R. , et al; PURIFI Study Group.
Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: a proof-of-concept study.
Hepatology 2016;
64 (01) 189-199
We do not assume any responsibility for the contents of the web pages of other providers.